TCL Archive In Brief: Breast Cancer Stamp Unveiled; Payne Moves To MSK; Survivor To Bike Across U.S. July 31, 1998
TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005
TCL Archive Studies Question PSA Screening: PLCO Trial Finds No Survival Advantage, European Trial Finds Benefit At High Cost March 20, 2009
